tiprankstipranks
Novonesis A/S (UK) (MX:NSISN)
LSE:NSISN
Mexico Market
NSISN
Novonesis
RESEARCH TOOLSreports

Novonesis (NSISN) Stock Forecast & Price Target

― Followers
See the Price Targets and Ratings of:

NSISN Analyst Ratings

Strong Buy
6Ratings
Strong Buy
6 Buy
0 Hold
0 Sell
Based on 6 analysts giving stock ratings to
Novonesis
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

NSISN Stock 12 Month Forecast

Average Price Target

$1,296.30
Based on 6 Wall Street analysts offering 12 month price targets for Novonesis in the last 3 months. The average price target is $1,296.30 with a high forecast of $1,389.85 and a low forecast of $1,176.03. The average price target represents a ― change from the last price of ―.
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
Highest Price Target$1,390Average Price Target$1,296Lowest Price Target$1,176
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on MX:NSISN
Lisa De Neve
Morgan Stanley
Morgan Stanley
$1,389.85
Buy
―
Reiterated
07/20/26
Novonesis (0Q4U) Receives a Buy from Morgan Stanley
J.P. Morgan Analyst forecast on MX:NSISN
Chetan Udeshi
J.P. Morgan
J.P. Morgan
$1,336.39→$1,389.85
Buy
―
Reiterated
07/08/26
Novonesis price target raised to DKK 520 from DKK 500 at JPMorganNovonesis price target raised to DKK 520 from DKK 500 at JPMorgan
Jefferies Analyst forecast on MX:NSISN
Marcus Dunford-Castro
Jefferies
Jefferies
$1,202.76→$1,282.94
Buy
―
Reiterated
07/02/26
Jefferies Sticks to Its Buy Rating for Novonesis (0Q4U)
Deutsche Bank Analyst forecast on MX:NSISN
Virginie Boucher-Ferte
Deutsche Bank
Deutsche Bank
$1,282.94→$1,309.67
Buy
―
Reiterated
06/30/26
Novonesis price target raised to DKK 490 from DKK 480 at Deutsche BankNovonesis price target raised to DKK 490 from DKK 480 at Deutsche Bank
Kepler Capital Analyst forecast on MX:NSISN
Philip Ngotho
Kepler Capital
Kepler Capital
$1,229.48
Buy
―
Reiterated
05/18/26
Novonesis (0Q4U) Gets a Buy from Kepler Capital
Citi Analyst forecast on MX:NSISN
Ranulf Orr
Citi
Citi
$1,109.21→$1,176.03
Buy
―
Reiterated
05/08/26
Novonesis price target raised to DKK 440 from DKK 415 at CitiNovonesis price target raised to DKK 440 from DKK 415 at Citi
Barclays Analyst forecast on MX:NSISN
Alex Sloane
Barclays
Barclays
$1,229.48→$1,256.21
Buy
―
Reiterated
05/05/26
Barclays Remains a Buy on Novonesis (0Q4U)
Rothschild & Co Redburn Analyst forecast on MX:NSISN
Artem Chubarov
Rothschild & Co Redburn
Rothschild & Co Redburn
$1,189.39
Buy
―
Upgraded
03/27/26
Novonesis upgraded to Buy from Neutral at Rothschild & Co RedburnNovonesis upgraded to Buy from Neutral at Rothschild & Co Redburn
Berenberg Bank Analyst forecast on MX:NSISN
Sebastian Bray
Berenberg Bank
Berenberg Bank
$1,277.59→$1,095.84
Buy
―
Reiterated
03/11/26
Novonesis price target lowered to DKK 410 from DKK 478 at BerenbergNovonesis price target lowered to DKK 410 from DKK 478 at Berenberg
Goldman Sachs Analyst forecast on MX:NSISN
Georgina Fraser CFA
Goldman Sachs
Goldman Sachs
$1,470.03
Buy
―
Reiterated
11/11/25
New Buy Rating for Novonesis (0Q4U), the Technology Giant
UBS Analyst forecast on MX:NSISN
Charles Eden
UBS
UBS
$1,256.21→$1,189.39
Buy
―
Reiterated
09/30/25
Novonesis (0Q4U): New Buy Recommendation for This Technology Giant
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on MX:NSISN
Lisa De Neve
Morgan Stanley
Morgan Stanley
$1,389.85
Buy
―
Reiterated
07/20/26
Novonesis (0Q4U) Receives a Buy from Morgan Stanley
J.P. Morgan Analyst forecast on MX:NSISN
Chetan Udeshi
J.P. Morgan
J.P. Morgan
$1,336.39→$1,389.85
Buy
―
Reiterated
07/08/26
Novonesis price target raised to DKK 520 from DKK 500 at JPMorganNovonesis price target raised to DKK 520 from DKK 500 at JPMorgan
Jefferies Analyst forecast on MX:NSISN
Marcus Dunford-Castro
Jefferies
Jefferies
$1,202.76→$1,282.94
Buy
―
Reiterated
07/02/26
Jefferies Sticks to Its Buy Rating for Novonesis (0Q4U)
Deutsche Bank Analyst forecast on MX:NSISN
Virginie Boucher-Ferte
Deutsche Bank
Deutsche Bank
$1,282.94→$1,309.67
Buy
―
Reiterated
06/30/26
Novonesis price target raised to DKK 490 from DKK 480 at Deutsche BankNovonesis price target raised to DKK 490 from DKK 480 at Deutsche Bank
Kepler Capital Analyst forecast on MX:NSISN
Philip Ngotho
Kepler Capital
Kepler Capital
$1,229.48
Buy
―
Reiterated
05/18/26
Novonesis (0Q4U) Gets a Buy from Kepler Capital
Citi Analyst forecast on MX:NSISN
Ranulf Orr
Citi
Citi
$1,109.21→$1,176.03
Buy
―
Reiterated
05/08/26
Novonesis price target raised to DKK 440 from DKK 415 at CitiNovonesis price target raised to DKK 440 from DKK 415 at Citi
Barclays Analyst forecast on MX:NSISN
Alex Sloane
Barclays
Barclays
$1,229.48→$1,256.21
Buy
―
Reiterated
05/05/26
Barclays Remains a Buy on Novonesis (0Q4U)
Rothschild & Co Redburn Analyst forecast on MX:NSISN
Artem Chubarov
Rothschild & Co Redburn
Rothschild & Co Redburn
$1,189.39
Buy
―
Upgraded
03/27/26
Novonesis upgraded to Buy from Neutral at Rothschild & Co RedburnNovonesis upgraded to Buy from Neutral at Rothschild & Co Redburn
Berenberg Bank Analyst forecast on MX:NSISN
Sebastian Bray
Berenberg Bank
Berenberg Bank
$1,277.59→$1,095.84
Buy
―
Reiterated
03/11/26
Novonesis price target lowered to DKK 410 from DKK 478 at BerenbergNovonesis price target lowered to DKK 410 from DKK 478 at Berenberg
Goldman Sachs Analyst forecast on MX:NSISN
Georgina Fraser CFA
Goldman Sachs
Goldman Sachs
$1,470.03
Buy
―
Reiterated
11/11/25
New Buy Rating for Novonesis (0Q4U), the Technology Giant
UBS Analyst forecast on MX:NSISN
Charles Eden
UBS
UBS
$1,256.21→$1,189.39
Buy
―
Reiterated
09/30/25
Novonesis (0Q4U): New Buy Recommendation for This Technology Giant
Stocks with the Highest Top Analyst Consensus in the General Sector
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock
CBRSCerebras Systems, Inc. Class A
FRVOFervo Energy Company Class A
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Novonesis

3 Months
Alex SloaneBarclays
Success Rate
14/21 ratings generated profit
67%
Average Return
+3.90%
Copying Alex Sloane's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +3.90% per trade.
1 Year
Chetan UdeshiJ.P. Morgan
Success Rate
9/12 ratings generated profit
75%
Average Return
+5.60%
Copying Chetan Udeshi's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +5.60% per trade.
2 Years
Chetan UdeshiJ.P. Morgan
Success Rate
11/12 ratings generated profit
92%
Average Return
+9.12%
Copying Chetan Udeshi's trades and holding each position for 2 Years would result in 91.67% of your transactions generating a profit, with an average return of +9.12% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

NSISN Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
0
Buy
7
11
8
9
4
Hold
2
2
1
2
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
9
13
9
11
5
In the current month, NSISN has received 4 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. NSISN average Analyst price target in the past 3 months is 1,296.30.
Each month's total comprises the sum of three months' worth of ratings.

NSISN Financial Forecast

NSISN Earnings Forecast

Next quarter’s earnings estimate for NSISN is $10.55 with a range of $10.55 to $10.55. The previous quarter’s EPS was $8.49. NSISN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 49.87% of the time in the same period. In the last calendar year NSISN has Performed in-line its overall industry.
Next quarter’s earnings estimate for NSISN is $10.55 with a range of $10.55 to $10.55. The previous quarter’s EPS was $8.49. NSISN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 49.87% of the time in the same period. In the last calendar year NSISN has Performed in-line its overall industry.

NSISN Sales Forecast

Next quarter’s sales forecast for NSISN is $22.10B with a range of $21.89B to $22.30B. The previous quarter’s sales results were $22.26B. NSISN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 62.37% of the time in the same period. In the last calendar year NSISN has Performed in-line its overall industry.
Next quarter’s sales forecast for NSISN is $22.10B with a range of $21.89B to $22.30B. The previous quarter’s sales results were $22.26B. NSISN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 62.37% of the time in the same period. In the last calendar year NSISN has Performed in-line its overall industry.

NSISN Stock Forecast FAQ

What is MX:NSISN’s average 12-month price target, according to analysts?
Based on analyst ratings, Novonesis A/S (UK)’s 12-month average price target is 1,296.30.
    What is MX:NSISN’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for MX:NSISN, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Novonesis A/S (UK) a Buy, Sell or Hold?
        Novonesis A/S (UK) has a consensus rating of Strong Buy, which is based on 6 buy ratings, 0 hold ratings and 0 sell ratings.
          What is Novonesis A/S (UK)’s share price target?
          The average share price target for Novonesis A/S (UK) is 1,296.30. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $1,389.85 ,and the lowest forecast is $1,176.03. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Novonesis A/S (UK)?
            Novonesis A/S (UK)’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.
              How can I buy shares of Novonesis A/S (UK)?
              To buy shares of MX:NSISN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.